Author:
Bergmann T K,Brasch-Andersen C,Gréen H,Mirza M,Pedersen R S,Nielsen F,Skougaard K,Wihl J,Keldsen N,Damkier P,Friberg L E,Peterson C,Vach W,Karlsson M O,Brosen K
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference50 articles.
1. Thigpen JT . Chemotherapy for advanced ovarian cancer: overview of randomized trials. Semin Oncol 2000; 27: 11–16.
2. Vasey PA, Jayson GC, Gordon A, Gabra H, Coleman R, Atkinson R et al. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. J Natl Cancer Inst 2004; 96: 1682–1691.
3. Harris JW, Rahman A, Kim BR, Guengerich FP, Collins JM . Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. Cancer Res 1994; 54: 4026–4035.
4. Rahman A, Korzekwa KR, Grogan J, Gonzalez FJ, Harris JW . Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8. Cancer Res 1994; 54: 5543–5546.
5. Kumar G, Ray S, Walle T, Huang Y, Willingham M, Self S et al. Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6 alpha-hydroxytaxol. Cancer Chemother Pharmacol 1995; 36: 129–135.
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献